Session 6
Antivirals I

Programme

• 02:45 p.m. – 03:10 p.m. 20 Min. 5 Min.

  • Invited Talk
  • IT 07

  Novel antivirals against dengue virus

  • Johan Neyts (Leuven / BE)
• 03:10 p.m. – 03:35 p.m. 20 Min. 5 Min.

  • Invited Talk
  • IT 08

  Neutralizing antibodies for therapy

  • Marit van Gils (Amsterdam / NL)
• 03:35 p.m. – 04:00 p.m. 20 Min. 5 Min.

  • Invited Talk
  • IT 09

  CRISPR-Cas therapy towards an HIV cure

  • Elena Herrera-Carrillo (Amsterdam / NL)
• 04:00 p.m. – 04:15 p.m. 10 Min. 5 Min.

  • Abstract Talk
  • AT 15

  Combination therapy of pritelivir with acyclovir or foscarnet suppresses evolution of HSV-1 drug resistance

  • Hanna Schalkwijk (Leuven / BE)

   Antivirals, Virus-host interactions: entry, replication, assembly, egress
• 04:15 p.m. – 04:30 p.m. 10 Min. 5 Min.

  • Abstract Talk
  • AT 50

  Pharmacological repositioning of Plitidepsin as an antiviral agent

  • Dr. Jose Jimeno (Madrid / ES)

   Antivirals, SARS -CoV2 and other coronaviruses